Welcome to the board! Yes, you are correct NP stated in the recent published interview:

"Then we have triple negative breast cancer, in which patients die within nine months, and we are able to give some results of whether it is working or not within three to four months, which we believe it is going to work, because the animal data has been simply stunning!"

https://ceocfointerviews.com/interviews/CytoDyn19.htm

I don't expect results before 22 May, but there could be positive news on this front relatively quickly once they inject. Per the current clinic trial website, the trial cycle is 21 days and will follow a "3+3" designed to determine the maximum tolerated dose (MTD). While I don't think it is likely to get TNBC interim results before the meeting, we may get some indication from the company as I would hope or think they will be complete with at least one cycle by then. If not addressed before the meeting, I'm sure this will be a question that will be asked.

https://clinicaltrials.gov/ct2/show/NCT038383...amp;rank=3